Case Report
BibTex RIS Cite

Year 2024, Volume: 4 Issue: 2, 61 - 63, 29.04.2024
https://doi.org/10.56016/dahudermj.1267120
https://izlik.org/JA38CN75ZT

Abstract

References

  • Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, Beyer G, Sutton R. Acute Pancreatitis: Diagnosis and Treatment. Drugs. 2022 Aug;82(12):1251-1276. doi: 10.1007/s40265-022-01766-4.
  • Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf. 2008;31(10):823-37. doi: 10.2165/00002018-200831100-00002.
  • Simons-Linares CR, Elkhouly MA, Salazar MJ. Drug-Induced Acute Pancreatitis in Adults: An Update. Pancreas. 2019 Nov/Dec;48(10):1263-1273. doi: 10.1097/MPA.0000000000001428.
  • Juanatey A, Blanco-Garcia L, Tellez N. Ocrelizumab: its efficacy and safety in multiple sclerosis. Rev Neurol. 2018 Jun 16;66(12):423-433.
  • Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol. 2011 Dec;106(12):2183-8. doi: 10.1038/ajg.2011.303.
  • Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013 Mar 25;173(6):444-9. doi: 10.1001/jamainternmed.2013.2737.
  • Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007 Jun;5(6):648-61; quiz 644. doi: 10.1016/j.cgh.2006.11.023.
  • Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000 May;12(5):597-605. doi: 10.1093/intimm/12.5.597.

A case of recurrent acute pancreatitis following ocrelizumab use

Year 2024, Volume: 4 Issue: 2, 61 - 63, 29.04.2024
https://doi.org/10.56016/dahudermj.1267120
https://izlik.org/JA38CN75ZT

Abstract

Acute pancreatitis is an acute inflammatory process of the pancreas. Drugs are a relatively rare cause of acute pancreatitis with an incidence of 0.1-2%. Ocrelizumab is a monoclonal antibody that causes peripheral B lymphocyte suppression by targeting CD20 receptors on B lymphocytes. In this case report, we aimed to present a case of acute pancreatitis after ocrelizumab use. It is thought that suppression of B lymphocytes by ocrelizumab may induce proinflammatory cytokine release and may also cause pancreatitis by disrupting T lymphocyte regulation. Therefore, ocrelizumab should be considered in the etiology of pancreatitis in patients receiving ocrelizumab treatment.

References

  • Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, Beyer G, Sutton R. Acute Pancreatitis: Diagnosis and Treatment. Drugs. 2022 Aug;82(12):1251-1276. doi: 10.1007/s40265-022-01766-4.
  • Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf. 2008;31(10):823-37. doi: 10.2165/00002018-200831100-00002.
  • Simons-Linares CR, Elkhouly MA, Salazar MJ. Drug-Induced Acute Pancreatitis in Adults: An Update. Pancreas. 2019 Nov/Dec;48(10):1263-1273. doi: 10.1097/MPA.0000000000001428.
  • Juanatey A, Blanco-Garcia L, Tellez N. Ocrelizumab: its efficacy and safety in multiple sclerosis. Rev Neurol. 2018 Jun 16;66(12):423-433.
  • Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol. 2011 Dec;106(12):2183-8. doi: 10.1038/ajg.2011.303.
  • Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013 Mar 25;173(6):444-9. doi: 10.1001/jamainternmed.2013.2737.
  • Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007 Jun;5(6):648-61; quiz 644. doi: 10.1016/j.cgh.2006.11.023.
  • Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000 May;12(5):597-605. doi: 10.1093/intimm/12.5.597.
There are 8 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Case Report
Authors

Elif Işıklar 0009-0001-9269-6070

Berivan Akdoğan This is me 0000-0002-9650-4283

Uygar Yavaş This is me 0009-0002-3961-0642

İsmail Demir 0000-0001-7787-1443

Submission Date August 20, 2023
Publication Date April 29, 2024
DOI https://doi.org/10.56016/dahudermj.1267120
IZ https://izlik.org/JA38CN75ZT
Published in Issue Year 2024 Volume: 4 Issue: 2

Cite

APA Işıklar, E., Akdoğan, B., Yavaş, U., & Demir, İ. (2024). A case of recurrent acute pancreatitis following ocrelizumab use. DAHUDER Medical Journal, 4(2), 61-63. https://doi.org/10.56016/dahudermj.1267120
AMA 1.Işıklar E, Akdoğan B, Yavaş U, Demir İ. A case of recurrent acute pancreatitis following ocrelizumab use. DAHUDER MJ. 2024;4(2):61-63. doi:10.56016/dahudermj.1267120
Chicago Işıklar, Elif, Berivan Akdoğan, Uygar Yavaş, and İsmail Demir. 2024. “A Case of Recurrent Acute Pancreatitis Following Ocrelizumab Use”. DAHUDER Medical Journal 4 (2): 61-63. https://doi.org/10.56016/dahudermj.1267120.
EndNote Işıklar E, Akdoğan B, Yavaş U, Demir İ (April 1, 2024) A case of recurrent acute pancreatitis following ocrelizumab use. DAHUDER Medical Journal 4 2 61–63.
IEEE [1]E. Işıklar, B. Akdoğan, U. Yavaş, and İ. Demir, “A case of recurrent acute pancreatitis following ocrelizumab use”, DAHUDER MJ, vol. 4, no. 2, pp. 61–63, Apr. 2024, doi: 10.56016/dahudermj.1267120.
ISNAD Işıklar, Elif - Akdoğan, Berivan - Yavaş, Uygar - Demir, İsmail. “A Case of Recurrent Acute Pancreatitis Following Ocrelizumab Use”. DAHUDER Medical Journal 4/2 (April 1, 2024): 61-63. https://doi.org/10.56016/dahudermj.1267120.
JAMA 1.Işıklar E, Akdoğan B, Yavaş U, Demir İ. A case of recurrent acute pancreatitis following ocrelizumab use. DAHUDER MJ. 2024;4:61–63.
MLA Işıklar, Elif, et al. “A Case of Recurrent Acute Pancreatitis Following Ocrelizumab Use”. DAHUDER Medical Journal, vol. 4, no. 2, Apr. 2024, pp. 61-63, doi:10.56016/dahudermj.1267120.
Vancouver 1.Elif Işıklar, Berivan Akdoğan, Uygar Yavaş, İsmail Demir. A case of recurrent acute pancreatitis following ocrelizumab use. DAHUDER MJ. 2024 Apr. 1;4(2):61-3. doi:10.56016/dahudermj.1267120

INDEXING & ABSTRACTING & ARCHIVING

        35061


DAHUDER Medical Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

35194